Back to Allspring Global Investments Holdings, LLC Allspring Global Investments Holdings, LLC

OVID

Showing 6 of 8 quarters

Position history for Allspring Global Investments Holdings, LLCAllspring Global Investments Holdings, LLC's holdings in Ovid Therapeutics Inc.

Yes. Allspring Global Investments holds 10,152 shares of OVID (Ovid Therapeutics), worth $24,263, as of its Q3 2026 13F filing. It reduced the position by 1,110 shares (-9.9%) from Q2 2026. Allspring Global Investments has held OVID since Q2 2025, across 6 quarterly 13F filings.

Current Value

$24,263

Current Shares

10,152

Total Value Change

+$12,164

Total Shares Change

-28,135

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
10,152
-9.9%
$24,2630.0%$2.49
0
2026-Q2
Unchanged
11,262
0.0%
$30,5760.0%$2.69
0
2026-Q1
Unchanged
11,262
0.0%
$23,7630.0%$2.22
0
2025-Q4
Unchanged
11,262
0.0%
$18,6950.0%$1.63
0
2025-Q3
Decreased
11,262
-70.6%
$15,4290.0%$1.30
0
2025-Q2
New
38,287
-
$12,0990.0%$0.33
27

Other major holders of OVID: Jupiter Topco LLC, BlackRock, Inc., RA Capital Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used